Relmada Therapeutics, Inc.
Extract: Charter Amendment (Plain English Desc) from a 8-K on 09/22/2022   Download
SEC Document
SEC Filing

On September 22, the Company filed a Certificate of Amendment to its Articles of Incorporation, as amended, with the Secretary of State of Nevada to increase the number of authorized shares of the Company’s common stock from 50,000,000 to 150,000,000 shares (the “Charter Amendment”).

 

As previously disclosed in Item 5.07 of the Current Report on Form 8-K filed with the Securities and Exchange Commission on June 1, 2022, the Charter Amendment was approved by the Company’s stockholders at the 2022 annual meeting of stockholders held on May 25, 2022.